CANDACE RENFRO: Open Payments
NPI 1841928512 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 37 payments from 16 companies in 2025. Trend: 2023 $1,058 · 2024 $513 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $154 |
| Lilly USA, LLC | 8 | $107 |
| PFIZER INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
Products named: MOUNJARO, JARDIANCE, PREVNAR 20, Rybelsus, Ozempic, Wegovy, SPRAVATO, INSPIRE.
Industry payments across TX — which companies pay providers there.
